Cargando…
Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer
We herein report the case of a 79-year-old patient with unresectable stage III non-small cell lung cancer who developed immune-related hepatitis caused by durvalumab administration. Durvalumab was administered at 10 mg/kg every two weeks after the treatment with carboplatin (AUC2), paclitaxel (35 mg...
Autores principales: | Nakamura, Masakatsu, Otsuka, Toshimi, Hayashi, Ranji, Horita, Tomoe, Ota, Masafumi, Sakurai, Naoko, Takano, Hikaru, Hayashi, Tasuku, Kumagai, Motona, Yamada, Sohsuke, Arisawa, Tomiyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691038/ https://www.ncbi.nlm.nih.gov/pubmed/32669493 http://dx.doi.org/10.2169/internalmedicine.4699-20 |
Ejemplares similares
-
Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa
por: Takano, Hikaru, et al.
Publicado: (2020) -
Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis
por: Sakurai, Naoko, et al.
Publicado: (2020) -
Genetic polymorphisms of MAFK, encoding a small Maf protein, are associated with susceptibility to ulcerative colitis in Japan
por: Arisawa, Tomiyasu, et al.
Publicado: (2017) -
Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders
por: Nakamura, Masakatsu, et al.
Publicado: (2021) -
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium
por: Nomura, Tomoe, et al.
Publicado: (2013)